AliveCor has launched KardiaACCESS, a 10-year program under the CMS ACCESS Model offering eligible Original Medicare Part B beneficiaries connected monitoring devices, virtual clinician visits and lifestyle coaching at no out-of-pocket cost. The program is structured into two tracks — early risk support for hypertension, high cholesterol, prediabetes or overweight, and management of established Type 2 diabetes, chronic kidney disease or cardiovascular disease. It represents a shift toward continuous, home-based cardiometabolic surveillance in a population where more than 70 percent of adults aged 60 to 79 already carry cardiovascular disease.
Key Points
- Ten-year CMS-aligned program, no out-of-pocket cost, 48 states
- Two tracks separate early risk from established chronic disease
- Connected ECG and blood pressure devices paired with clinician coaching
Longevity Analysis
Cardio-kidney-metabolic decline rarely announces itself; it accumulates through blood pressure and glucose drift that remains invisible between annual appointments. Placing ECG and pressure measurement in the home converts intermittent snapshots into a continuous signal, allowing vascular strain, filtration decline and glucose dysregulation to be read as one connected process rather than three separate diagnoses. The program's structural value lies less in the hardware than in the coaching and scheduled contact that determine whether measurement actually translates into sustained behavioral change.
Original published by Longevity.Technology.